Abstract
Purpose
To report the outcomes of the Biodesign Fistula Plug as an alternative treatment for enterocutaneous fistulae by presenting our institutional experience from 2013 to 2020.
Materials and Methods
A retrospective review of all attempted fistula closures utilizing the Biodesign Fistula Plug at a single institution from 2012 to 2020 was performed under IRB approval and in compliance with HIPAA. Patient demographics were obtained including age at the time of the procedure, etiology, location of the fistula, history of malignancy, prior chemotherapy or radiation, and history of prior surgery or other interventions. Patient follow-up was performed through 7/2020 to evaluate for fistula closure, complications, or subsequent treatments.
Results
There were 25 patients who underwent 35 Biodesign Fistula Plug placements. Of these, 7 procedures were successful, defined as closure of the fistula, and 28 procedures were unsuccessful, defined as persistent fistula output or requiring further intervention on the EC fistula. There were 7 major complications, SIR classification D = 3, E = 2 and F = 2. No statistically significant risk factors were found predicting fistula plug failure although there was a trend towards patients with malignancy having unsuccessful outcome (p = 0.057). The average number of procedures for patients with successful closure was 1.4 versus 4.22 for those with unsuccessful closure. The average time to plug failure was 27.8 days (range 3–163 days), and the average time to fistula closure following plug placement was 21.4 days (range 14–30).
Conclusion
Enterocutaneous fistulae are complex and morbid with no good treatment options. These findings demonstrate the Biodesign Fistula Plug can be successful in select patients, however, should be used with great caution due to high rate of failure and complications including two patient deaths.
References
Tuma F, Crespi Z, Wolff CJ, Daniel DT, Nassar AK. Enterocutaneous fistula: a simplified clinical approach. Cureus. 2020;12(4):e7789. https://doi.org/10.7759/cureus.7789.
Gribovskaja-Rupp I, Melton GB. Enterocutaneous fistula: proven strategies and updates. Clin Colon Rectal Surg. 2016;29(2):130–7. https://doi.org/10.1055/s-0036-1580732.
Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J Gastrointest Surg. 2006;10(3):455–64. https://doi.org/10.1016/j.gassur.2005.08.001.
Williams LJ, Zolfaghari S, Boushey RP. Complications of enterocutaneous fistulas and their management. Clin Colon Rectal Surg. 2010;23(3):209–20. https://doi.org/10.1055/s-0030-1263062.
Haffejee AA. Surgical management of high output enterocutaneous fistulae: a 24-year experience. Curr Opin Clin Nutr Metab Care. 2004;7(3):309–16. https://doi.org/10.1097/00075197-200405000-00011.
Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg. 2008;32(3):436–43. https://doi.org/10.1007/s00268-007-9304-z (discussion 44).
Li J, Ren J, Zhu W, Yin L, Han J. Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J (Engl). 2003;116(2):171–5.
Campos AC, Andrade DF, Campos GM, Matias JE, Coelho JC. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg. 1999;188(5):483–90. https://doi.org/10.1016/s1072-7515(99)00038-1.
Rahbour G, Gabe SM, Ullah MR, Thomas GP, Al-Hassi HO, Yassin NA, et al. Seven-year experience of enterocutaneous fistula with univariate and multivariate analysis of factors associated with healing: development of a validated scoring system. Colorectal Dis. 2013;15(9):1162–70. https://doi.org/10.1111/codi.12363.
Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg. 1978;188(4):460–7. https://doi.org/10.1097/00000658-197810000-00003.
Erdmann D, Drye C, Heller L, Wong MS, Levin SL. Abdominal wall defect and enterocutaneous fistula treatment with the vacuum-assisted closure (VAC) system. Plast Reconstr Surg. 2001;108(7):2066–8. https://doi.org/10.1097/00006534-200112000-00036.
Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg. 2006;93(9):1045–55. https://doi.org/10.1002/bjs.5396.
Ballard DH, Erickson AEM, Ahuja C, Vea R, Sangster GP, D’Agostino HB. Percutaneous management of enterocutaneous fistulae and abscess-fistula complexes. Dig Dis Interv. 2018;2(2):131–40. https://doi.org/10.1055/s-0038-1660452.
Lee SH. Surgical management of enterocutaneous fistula. Korean J Radiol. 2012;13(Suppl 1):S17-20. https://doi.org/10.3348/kjr.2012.13.S1.S17.
Gonzalez-Pinto I, Gonzalez EM. Optimising the treatment of upper gastrointestinal fistulae. Gut. 2001;49(Suppl 4):iv22-31. https://doi.org/10.1136/gut.49.suppl_4.iv21.
Srinivasa RN, Srinivasa RN, Gemmete JJ, Hage AN, Sherk W, Chick JFB. Laser ablation facilitates closure of chronic enterocutaneous fistulae. J Vasc Interv Radiol. 2018;29(3):335–9. https://doi.org/10.1016/j.jvir.2017.10.028.
Smith TA, Hardman RL, Jenkins L, Marashi K, O’Hara R, Cizman Z. Extracellular matrix enterocutaneous fistula plugs show promise for low-flow colocutaneous and enterocutaneous fistulae. J Vasc Interv Radiol. 2012;32(1):128–34. https://doi.org/10.1016/j.jvir.2020.08.033.
Crespo Vallejo E, Martinez-Galdamez M, Del Olmo ML, Crespo Brunet E, Santos Martin E. Percutaneous treatment of a duodenocutaneous high-flow fistula using a new biological plug. Diagn Interv Radiol. 2015;21(3):247–51. https://doi.org/10.5152/dir.2014.14421.
Brooks NE, Idrees JJ, Steinhagen E, Giglia M, Stein SL. The impact of enteric fistulas on US hospital systems. Am J Surg. 2021;221(1):26–9. https://doi.org/10.1016/j.amjsurg.2020.06.017.
Nichols F, Overly A. Novel approach for enterocutaneous fistula treatment with the use of viable cryopreserved placental membrane. Case Rep Surg. 2016;2016:8797691. https://doi.org/10.1155/2016/8797691.
Kumar N, Larsen MC, Thompson CC. Endoscopic management of gastrointestinal fistulae. Gastroenterol Hepatol (N Y). 2014;10(8):495–52.
Acknowledgements
We would like to acknowledge and thank Dr. Karen Brown for her guidance with this study and edits to the manuscript.
Funding
No funds, grants, or other support was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
CK research grant from Boston Scientific. LJ is a paid consultant for Cook Medical (Bloomington, Indiana) and Becton, Dickinson and Company (Franklin Lakes, New Jersey). The remainder of the authors have no conflicts of interest to declare that are relevant to the content of this article.
Ethical Approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the University of Utah approved this study.
Informed Consent
For this type of study informed consent is not required.
Consent for Publication
For this type of study consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaufman, C., Adkison, G., Smith, T. et al. Single Institution Outcome of Minimally Invasive Enterocutaneous Fistula Management Utilizing the Biodesign® Fistula Plug. Cardiovasc Intervent Radiol 45, 846–851 (2022). https://doi.org/10.1007/s00270-022-03099-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-022-03099-x